Users of Abbott’s CGM device can now view data and gain additional insights through Glooko’s diabetes management platform.

Glooko announced today that its platform now supports the Abbott FreeStyle Libre continuous glucose monitoring (CGM) in the U ...

For individuals with type 1 diabetes, low-glucose alerts improve the time below range for drivers and reduce the incidence of ...

The US Food and Drug Administration (FDA) has granted Abbott an investigational device exemption to evaluate the company’s ...

ATTD conference, experts debated whether patients who use continuous glucose monitoring should aim for normal glycemia.

Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...

Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...

A randomized study from Insulet of adults and children with Type 1 diabetes found that moving from multiple daily injections ...

Adults with insulin-treated type 2 diabetes had greater HbA1c reductions and larger improvement in time in range with use of ...

Sequel Med Tech has announced that Abbott’s FreeStyle Libre 3 Plus sensor will be the first continuous glucose monitoring device to work with its twiist Automated Insulin Delivery (AID) System powered ...

Participants began with an average HbA1c level of 8.1%. After three months, people who used Omnipod 5 improved HbA1c by an ...